Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

The drugmaker Eli Lilly reports its third-quarter results early Thursday, as questions loom about what kind of deal it will ...

Bausch Health recently stopped participating in Medicaid and a federal government drug discount program known as 340B ...

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge in biotech funding rounds and public offerings, and ...

The Hollywood star sat down with Newsweek to discuss his next big project: upping enrollment in clinical trials.

Lilly and NVIDIA’s supercomputer marks the world's first NVIDIA DGX SuperPOD with DGX B300 systems, and is powered by more than 1,000 B300 GPUs on a unified networking fabric, meaning communication ...

Eli Lilly ( LLY) is expected to see a multi-fold increase in its earnings during its third quarter earnings, which is scheduled for October 29 after markets close. The pharma giant is expected to ...

"Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer" was originally created and published by Pharmaceutical ...

Eli Lilly and Walmart said they have teamed up to boost access to the pharma giant's weight loss drug Zepbound, allowing U.S.

The drugmaker hopes an Nvidia-chip powered supercomputer will help it find new drugs and accelerate lengthy R&D timelines.

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...